Bacterial lysates in allergic rhinitis and chronic rhinosinusitis: Mechanisms and clinical evidence
Open Access
- 1 April 2025
- journal article
- review article
- Published by SAGE Publications in Science Progress
- Vol. 108 (2)
Abstract
Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are chronic inflammatory disorders of the upper airways with rising global prevalence, contributing significantly to health and socioeconomic burdens. Conventional treatments—including glucocorticoids, antibiotics, antihistamines, and leukotriene inhibitors—remain insufficient in targeting the underlying pathophysiology. Bacterial lysates (BLs), functioning as immunomodulators, activate both innate, and adaptive immune pathways, reestablish Th1/Th2 equilibrium, lower immunoglobulin E concentrations, and attenuate Th2-mediated inflammation. Emerging evidence indicates that BLs (e.g. OM-85, Broncho-Vaxom) markedly improve total nasal symptom scores in AR, suppress Th2 cytokine (IL-4 and IL-13) secretion, and reduce recurrence rates and surgical interventions in CRS. In conjunction with standard therapies, BLs enhance mucosal immune defense and contribute to sustained clinical efficacy. Following the Scale for the Assessment of Narrative Review Articles guidelines, this review critically evaluates the composition, manufacturing processes, immunoregulatory mechanisms, and clinical progress of BLs in AR and CRS, providing a conceptual framework for their clinical application.Keywords
Funding Information
- National Natural Science Foundation of China (No. 82160211)
- Jiangxi Provincial Nature Science Foundation (No. 2021BAG70031)
This publication has 79 references indexed in Scilit:
- In Vivo Effect of an Immunostimulating Bacterial Lysate on Human B LymphocytesInternational Journal of Immunopathology and Pharmacology, 2006
- Th1-orientated immunological properties of the bacterial extract OM-85-BV.2005
- Mucosal immunity and vaccinesNature Medicine, 2005
- Toll‐Like Receptor and Cytokine Expression Patterns of CD56+T Cells Are Similar to Natural Killer Cells in Response to Infection with Venezuelan Equine Encephalitis Virus RepliconsThe Journal of Infectious Diseases, 2003
- The role of T lymphocytes in the pathogenesis of asthmaJournal of Allergy and Clinical Immunology, 2003
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokinesThorax, 2000
- [Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children].1998
- Stimulation by a bacterial extract (broncho-vaxom) of the metabolic and functional activities of murine macrophagesInternational Journal of Immunopharmacology, 1989
- Broncho-Vaxom® in Children with Rhinosinusitis: A Double-Blind Clinical TrialORL, 1988